Wedad Al-Qahtani

Dr. Wedad Al-Qahtani

Naif Arab University for Security Sciences

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2021 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
SASawsan Abdullah Alshahrani
Sawsan Abdullah Alshahrani
Wedad Al-QahtaniWedad Al-Qahtani
Wedad Al-Qahtani
NANawaf Abdulrahman Almufareh
Nawaf Abdulrahman Almufareh
DDDalia Mostafa Domiaty
Dalia Mostafa Domiaty
GAGadah Ibraheem Albasher
Gadah Ibraheem Albasher
BABassam Ahmed Almutlaq
Bassam Ahmed Almutlaq
Background: Khat leaves contain the alkaloid cathinone. Research shows that khat might provoke toxicity, mutagenicity, as well as carcinogenicity.Methods: Two groups were identified as khat abusers and were categorized by abuse time and diagnosis of oral squamous cell carcinoma (OSCC). Here, 41 participants from Group 2 were short-term khat users, and 42 participants were long-term khat users. The control group included 30 healthy individuals.The coding exons included nine cancer-related genes and were analysed. The histopathological research was conducted with H&E staining along with the TP53 protein expression by implementing immunohistochemical analyses.Results: Here, 41 short-term khat users carried seven somatic mutations in four out of nine cancer-related genes: 29/41(70.73%)ARID1A, 24/41(58.53%)MLH1, 34/41(82.92%)PIK3CAand 36/41(87.80%)TP53. The 42 long-term khat users incorporated nine somatic mutations in five out of nin ecancer-related genes: 40/42(95.23%)ARID1A, 36/42(85.71%)ARID2, 29/42(69.04%)PIK3CA, 27/42(64.28%)MLH1, and 35/42(83.33%)TP53. Every khat user had somatic mutations related to OSCC affecting the gingiva and the lower lip. TP53 protein expression was confirmed in all immunohistochemical oral tests. Carcinoma was also positive in the histopathological analysis.Conclusions: Khat is a mutagenic and carcinogenic plant that provoked OSCC among short-term khat users (15 years of use).

19 December 2023 in Heliyon
Verified
Journal Article
Open access
DDDalia Mostafa Domiaty
Dalia Mostafa Domiaty
TATahani Mohamed Al-Hazani
Tahani Mohamed Al-Hazani
EAEman Alshehri
Eman Alshehri
HAHaya Zamil Aldajani
Haya Zamil Aldajani
NANaseem Abdulrahman Fahad Alqassim
Naseem Abdulrahman Fahad Alqassim
Wedad Al-QahtaniWedad Al-Qahtani
Wedad Al-Qahtani
Non-small cell lung cancer (NSCLC) is a pervasive and challenging global health concern. This research delves into the intricate relationship between NSCLC and ACE2 expression, exploring the potential impact of COVID-19 history on this interaction. Tissue samples were meticulously gathered from a cohort of 32 NSCLC patients, 18 of whom had a documented history of COVID-19 infection. The methodology included extensive investigations, such as cell dissociation, histopathological analysis, immunohistochemistry, cell culture, adhesion assays, immunocytochemistry, RNA isolation, and RT-PCR analysis. The results of this comprehensive study unearthed intriguing findings regarding ACE2 expression patterns within NSCLC tissues. Notably, variations were observed in ACE2 profiles between individuals with and without a prior record of COVID-19 infection, hinting at a dynamic interplay. These discoveries carry profound implications for both the understanding of NSCLC progression and the response to COVID-19 in patients with pre-existing NSCLC. The interrelationship between ACE2 expression, NSCLC, and COVID-19, as revealed in this study, may significantly influence patient outcomes and, potentially, therapeutic strategies. In summary, this research serves as an essential contribution to the growing body of knowledge on NSCLC, offering unique insights into the intricate connections between ACE2, COVID-19, and NSCLC. This information may open new avenues for tailored treatment approaches and clinical management strategies, ultimately benefiting patients grappling with NSCLC in the background of the current COVID-19 pandemic.

1 September 2021 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
AAAsma Algebaly
Asma Algebaly
QAQwait AlGabbani
Qwait AlGabbani
WAWedad Refaiea Al-Otaibi
Wedad Refaiea Al-Otaibi
AAAmani Mohammed Alotaibi
Amani Mohammed Alotaibi
FAFatimah Gh. Albani
Fatimah Gh. Albani
Wedad Al-QahtaniWedad Al-Qahtani
Wedad Al-Qahtani
Marjoram plants have varied pharmacological properties because they contain antioxidants. In the present study, to evaluate the effect of Origanum majorana, gathered from Abha, Saudi Arabia, on the growth of human breast cancer cells using MCF7. Fresh aerial parts from Origanum majorana were extracted at a low temperature (0 ℃/6 hours). Human MCF7 breast cancer cells were then treated with 4 separate fluctuated concentrations of 0, 50, 150, 200 and 350 µg/mL for 24 and 48 hours. The findings showed that Origanum majorana aqueous extract contained absolute phenolic content (TPC) was 58.24 mg equivalent/g DW, and the complete flavonoid content (TFC) 35.31 mg GAE equivalent/g DW in the Origanum majorana aqueous extract. The endurance of MCF7 cells after incubation with aqueous extract diminished, indicating that Origanum majorana is tumour cell selective. Origanum majorana extract increased the mRNA Expression of Apoptotic Genes in MCF7. Majorana aqueous extract expanded the activity of Caspase-7 action specifically at higher concentrations, 150, 200, and 350 µg/ml. Our findings indicate that Origanum majorana could induce apoptosis of human breast cancer cells. This is the first study that provides a basis for the use of aqueous Origanum majorana extracted at low temperature (0 °C/6 hours) as more effective anticancer treatment.

1 September 2023 in Journal of Applied Genetics
Verified
Journal Article
Closed access
PDF file
FSFatmah Ahmed Safhi
Fatmah Ahmed Safhi
TATahani Mohamed Ibrahim Al-Hazani
Tahani Mohamed Ibrahim Al-Hazani
AJAreej Saud Jalal
Areej Saud Jalal
MAManal Abdullah Alduwish
Manal Abdullah Alduwish
DADalal S. Alshaya
Dalal S. Alshaya
Wedad Al-QahtaniWedad Al-Qahtani
Wedad Al-Qahtani

29 May 2023 in Pathology - Research and Practice
Verified
Journal Article
Closed access
TATahani Mohamed Al-Hazani
Tahani Mohamed Al-Hazani
Wedad Al-QahtaniWedad Al-Qahtani
Wedad Al-Qahtani
MAMaha Abdulla Alwaili
Maha Abdulla Alwaili
DDDalia Mostafa Domiaty
Dalia Mostafa Domiaty
EAEman Alshehri
Eman Alshehri
TATahani Saeed Abboosh
Tahani Saeed Abboosh

7 January 2023 in Forensic Science International
Verified
Journal Article
Closed access
TATahani Mohamed Ibrahim Al-Hazani
Tahani Mohamed Ibrahim Al-Hazani
Wedad Al-QahtaniWedad Al-Qahtani
Wedad Al-Qahtani
TATahani Saeed Abboosh
Tahani Saeed Abboosh
FSFatmah Safhi
Fatmah Safhi
DADalal Sulaiman Alshaya
Dalal Sulaiman Alshaya
EAEman Alshehri
Eman Alshehri